期刊文献+

2020年嘉兴市南湖区适龄妇女宫颈癌筛查结果分析 被引量:3

Analysis of cervical cancer screening results of age-appropriate women in Nanhu District, Jiaxing city, 2020
原文传递
导出
摘要 目的分析2020年嘉兴市南湖区适龄妇女宫颈癌筛查结果,了解该地区宫颈癌的发病情况和特点,为开展该地妇女健康保健工作提供依据。方法2020年7—8月在嘉兴市南湖区对适龄妇女进行宫颈癌筛查,筛查个案基本信息和筛查结果均录入浙江省两癌检查项目管理系统。结果共筛查22062例妇女,年龄30~64岁,平均(49.78±5.34)岁;检出高危HPV阳性者1646例,HPV感染率随年龄增加而增加,HPV平均感染率前3位分别为HPV52(226.92‱)、58(117.81‱)及56(86.94‱)。检出宫颈低级别鳞状上皮内病变(LSIL)74例,宫颈高级别鳞状上皮内病变(HSIL)14例,原位腺癌3例,鳞状细胞癌1例。不同年龄组(30~40岁、41~50岁、51~60岁、>60岁)LSIL在阳性人群中的检出率分别为36.46‰、41.87‰、43.48‰、61.72‰;HSIL在阳性人群中的检出率分别为10.42‰、12.32‰、6.21‰、8.23‰,差异均无统计学意义(χ^(2)=2.05、1.29,均P>0.05)。不同年龄组宫颈癌鳞检出率比较,差异无统计学意义(χ^(2)=1.05,P=0.79)。结论HPV52、58为该地区感染率最高的型别,该区域高危型HPV16、18、52及58的感染与高级别宫颈上皮内病变的发生显著相关,重视围绝经期HPV阳性妇女的管理,重点加强对该年龄段妇女的宣传,以降低宫颈癌患病率,保障妇女健康。 Objective To analyze the cervical cancer screening results of women of appropriate age in Nanhu District,Jiaxing city in 2020,to understand the incidence and characteristics of cervical cancer in this area,and to provide a basis for women's health care work in this area.Methods From July to August 2020,women of the right age in Nanhu District of Jiaxing City were selected for cervical cancer screening.The basic information and results of the screening cases were recorded into Zhejiang Provincial Cancer and Cancer Examination Project Management System.Results A total of 22062 cases were screened,aged from 30 to 64 years old,with an average of(49.78±5.34)years old.Among 1646 high-risk cases,HPV positive cases were detected,and the rate of HPV infection increased with age,with the average HPV infection rate ranking among the top three of HPV52(226.92 per 10000 children),58(117.81 per 10000 children),and 56(86.94 per 10000 children).74 cases of low grade cervical squamous intraepithelial lesions(LSIL),14 cases of high grade cervical squamous intraepithelial lesions(HSIL),3 cases of adenocarcinoma in situ,and 1 case of squamous cell carcinoma were detected.The detection rate of LSIL in different age groups(30-40 years old,41-50 years old,51-60 years old,>60 years old)were 36.46‰,41.87‰,43.48‰and 61.72‰,respectively.The detection rates of HSIL in the positive population were 10.42‰,12.32‰,6.21‰and 8.23‰,respectively,and there were no statistical significance(χ^(2)=2.05,1.29,P>0.05).There was no significant difference in the detection rate of cervical cancer among different age groups(χ^(2)=1.05,P=0.79).Conclusion HPV52 and HPV58 were the highest infection types in this region.The infection of high-risk types HPV16,18,52 and 58 in this region was significantly correlated with the occurrence of HSIL.Pay attention to the management of perimenopausal women with HPV positivity,and focus on strengthening the publicity of women in this age group,so as to reduce the incidence of cervical cancer and protect women's health.
作者 金继华 袁军 钮文珍 祝国娅 吴晓杰 周琴琴 JIN Ji-Hua;YUAN Jun;NIU Wen-Zhen(Department of Gynecology,Jiaxing Maternal and Child Health Care Hospital,Jiaxing,Zhejiang 314001,China)
出处 《中国妇幼保健》 CAS 2022年第8期1454-1457,共4页 Maternal and Child Health Care of China
基金 浙江省医学会临床科研基金项目(2019ZYC-A133)。
关键词 宫颈癌 宫颈鳞状上皮内病变 筛查 Cervical cancer Cervical squamous intraepithelial lesion Screening
  • 相关文献

参考文献4

二级参考文献50

  • 1王华,陈亚宝,叶丽华,叶军,袁冬兰.应用支链DNA技术检测人乳头瘤病毒E6/E7mRNA在宫颈疾病筛查中的价值[J].中华临床医师杂志(电子版),2011,5(15):4362-4366. 被引量:29
  • 2何桂蓉,何林,李芳芳,刘忠.人乳头瘤病毒感染分子诊断的研究进展[J].中华检验医学杂志,2006,29(11):1048-1049. 被引量:7
  • 3Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 [J]. Int J Cancer, 2010, 127 (1Z): 2893-2917.
  • 4Tay SK, Ngan HY Chu TY, et al. Epidemiology of human papillomavirus infection and cervical cancer and future perspectives in Hong Kong, Singapore and Taiwan [J]. Vaccine, 2008, 26 (Suppl 12) : M60-M70.
  • 5Maree JE, Wright SC. Cervical cancer: does our message promote screening? A pilot study in a South African context [J]. Eur J Oncol Nurs, 2011, 15(2): 118- 123.
  • 6Eduardo C, Sue M, Patricia A, etal. Cervical cancer screening in developing eountries: why is it ineffective? The case of Mexico[J]. Arch Med Res,2009,30(3) :240.
  • 7Anttila A, Ronco G, Working Group on the Registration and Monitoring of Cervical Cancer Screening Programmes in the European Union: within the European Network for Information on Cancer (EUNICE). Description of the national, situation of cervical cancer screening in the member states of the European Union [J]. Eur J Cancer, 2009, 45(15) : 2685-2708.
  • 8van der Aa MA, Schutter EM, Looijen-Salamon M, et al. Differences in screening history, tumour characteristics and survival between women with screen-detected versus not screen- detected cervical cancer in the east of The Netherlands, 1992-2001 [J]. Eur J Obstet Gynecol Reprod Biol, 2008, 139(2), 204-209.
  • 9de Bie RP, Vergers-Spooren HC, Massuger LF, et al. Patients with cervical cancer: why did screening not prevent these cases.'? [J]. AmJ Obstet Gyneeol, 2011, 205(1): 64. e1-e7.
  • 10Konno R, Shin HR, Kim YT, et al. Human papillomavirus infection and cervical cancer prevention in Japan and Korea [J]. Vaccine, 2008, 26(Suppl 12): M30-M42.

共引文献98

同被引文献40

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部